Psychiatric Medicines in India: Why Public Healthcare Facilities and a Thriving Generics Industry Cannot Assure Access and Affordability
(2012; 5 pages)


This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian government’s pricing regulations and then enumerates recommendations for reform.

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019